Coissac Patrice 4
4 · ALEXION PHARMACEUTICALS INC · Filed Nov 2, 2012
Insider Transaction Report
Form 4
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
- Sale
Common Stock, par value $.0001 per share
2012-10-31$92.18/sh−12,030$1,108,925→ 1,118 total - Sale
Common Stock, par value $.0001 per share
2012-10-31$90.80/sh−33,546$3,045,977→ 52,336 total - Sale
Common Stock, par value $.0001 per share
2012-10-31$91.15/sh−39,188$3,571,986→ 13,148 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.00 - $90.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.00 - $91.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.00 - $92.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.